Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
—
—
—
The company makes bulk drug intermediates. It manufactures bulk drugs intermediates for Indian pharmaceutical companies on contract manufacturing basis. It also offers finish goods and fine chemicals.
Customise key metrics, see detailed forecasts, download stock data and more
Pledged promoter holdings is insignificant
In last 3 months, mutual fund holding of the company has almost stayed constant
Kimia Biosciences Ltd - 530313 - 31St Annual General Meeting ('AGM') Of The Company Is Scheduled To Be Held On Monday, December 30, 2024 At 04.00 Pm (IST) Through Video Conferencing/ Other Audio Visual Means ('VC/OAVM') | Download
Kimia Biosciences Ltd - 530313 - 31St Annual General Meeting ('AGM') Of The Company Is Scheduled To Be Held On Monday, December 30, 2024 At 04.00 Pm (IST) Through Video Conferencing/ Other Audio Visual Means ('VC/OAVM') | Download
Kimia Biosciences Ltd - 530313 - Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements), Regulations 2015. | Download
Kimia Biosciences Ltd - 530313 - Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements), Regulations 2015. | Download
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant